Feature | June 12, 2009

Isotope Crisis Highlights Timeliness of SNM Meeting

June 12, 2009 - With the Chalk River* nuclear reactor in Laurentian Hills, Ontario, Canada, shutdown, a reactor that supplies one-third** of the nuclear isotopes to the world, it was very timely when Canadian Prime Minister Stephen Harper welcomed the SNM annual meeting to Toronto, Canada, emphasizing the importance of molecular imaging to the future practice of medicine.

While the reactor is down for an undetermined amount of time, patients in North America requiring nuclear medicine procedures for diagnosing cancer, and neurological and cardiovascular diseases will face serious delays in medical treatment. As such, the medical isotope crisis places unprecedented importance on the SNM Annual Meeting, which called a press conference to address the issue: “Current Developments in the Medical Isotope Crisis and Molecular Imaging Research Breakthroughs,” on Monday, June 15, 11:30 a.m. to 12:45 p.m., in room 810 of the convention center.

The panel of top molecular imaging researchers, in addition to SNM President Robert W. Atcher, Ph.D, M.B.A., President-Elect Michael M. Graham, M.D., Ph.D, Peter S. Conti, M.D., Ph.D, and Henry N. Wagner, Jr., M.D., Johns Hopkins University, will discuss the latest developments surrounding the international medical isotope crisis; and announce major molecular imaging breakthroughs in the detection and treatment of cancers, heart and brain diseases.

Imaging Technology News will be providing all of the breaking news from the 2009 SNM Annual Meeting on ITNonline.net.

* The Chalk River nuclear reactor in Laurentian Hills, Ontario, Canada, is managed by the Atomic Energy of Canada Limited (AECL), a Canadian federal Crown corporation, that is a nuclear technology and engineering company that designed and developed the CANDU nuclear power reactor.
** According to medical doctor Jean-Luc Urbain, president of the Canadian Association of Nuclear Medicine, the Chalk River reactor supplies about 60 percent of the medical isotopes in the world, and the countries that will be most affected by the shortage are Canada and the U.S.

Read the 2017 article "FDA Clears Path for First Domestic Supply of Tc-99m Isotope." 

For more information: www.snm.org

Related Content

Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Overlay Init